GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blue Jet Healthcare Ltd (BOM:544009) » Definitions » Cash Flow from Financing

Blue Jet Healthcare (BOM:544009) Cash Flow from Financing : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Blue Jet Healthcare Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2025, Blue Jet Healthcare paid ₹0 Mil more to buy back shares than it received from issuing new shares. It received ₹0 Mil from issuing more debt. It paid ₹0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ₹0 Mil from paying cash dividends to shareholders. It received ₹0 Mil on other financial activities. In all, Blue Jet Healthcare spent ₹0 Mil on financial activities for the three months ended in Mar. 2025.


Blue Jet Healthcare Cash Flow from Financing Historical Data

The historical data trend for Blue Jet Healthcare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blue Jet Healthcare Cash Flow from Financing Chart

Blue Jet Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Cash Flow from Financing
-274.95 -561.45 -42.39 -19.86 -185.57

Blue Jet Healthcare Quarterly Data
Mar21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Blue Jet Healthcare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Blue Jet Healthcare's Cash from Financing for the fiscal year that ended in Mar. 2025 is calculated as:

Blue Jet Healthcare's Cash from Financing for the quarter that ended in Mar. 2025 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blue Jet Healthcare  (BOM:544009) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Blue Jet Healthcare's issuance of stock for the three months ended in Mar. 2025 was ₹0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Blue Jet Healthcare's repurchase of stock for the three months ended in Mar. 2025 was ₹0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Blue Jet Healthcare's net issuance of debt for the three months ended in Mar. 2025 was ₹0 Mil. Blue Jet Healthcare received ₹0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Blue Jet Healthcare's net issuance of preferred for the three months ended in Mar. 2025 was ₹0 Mil. Blue Jet Healthcare paid ₹0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Blue Jet Healthcare's cash flow for dividends for the three months ended in Mar. 2025 was ₹0 Mil. Blue Jet Healthcare received ₹0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Blue Jet Healthcare's other financing for the three months ended in Mar. 2025 was ₹0 Mil. Blue Jet Healthcare received ₹0 Mil on other financial activities.


Blue Jet Healthcare Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Blue Jet Healthcare's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Blue Jet Healthcare Business Description

Traded in Other Exchanges
Address
701, 702, 7th Floor, Plot No. 1 & 2, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, MH, IND, 400 705
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients.

Blue Jet Healthcare Headlines

No Headlines